Scientist Ii
Current
Astellas Pharma Us
Nov 2021 - Present
AeroLeads people directory · profile
Senthil Kumar Krishnaswamy Email & Phone Number
Scientist II
at
Astellas Pharma US
1 work email found
@astellas.com
3 phones found area 212 and 631
LinkedIn matched
✓ Verified Jun 2026
4 data sources
Profile completeness 100%
Current company
Astellas Pharma US
Role
Scientist II
Location
United States, United States, United States
Who is Senthil Kumar Krishnaswamy? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Senthil Kumar Krishnaswamy is listed as Scientist II at Astellas Pharma US, based in United States, United States, United States. AeroLeads shows a work email signal at astellas.com, phone signal with area code 212, 631, and a matched LinkedIn profile for Senthil Kumar Krishnaswamy.
Senthil Kumar Krishnaswamy previously worked as Scientist I at Abbott and Scientist at National Institute Of Health. Senthil Kumar Krishnaswamy holds Doctor Of Philosophy - Phd, Biochemistry And Molecular Biology from Niigata University Of Pharmacy And Applied Life Sciences.
Company email context
Email format at Astellas Pharma US
This section adds company-level context without repeating Senthil Kumar Krishnaswamy's masked contact details.
{first_initial}{last}@astellas.com
76% confidence
AeroLeads found 1 current-domain work email signal for Senthil Kumar Krishnaswamy. Compare company email patterns before reaching out.
Profile bio
About Senthil Kumar Krishnaswamy
An innovative, enthusiastic and adaptive Biochemist, and Molecular Biologist with 10 years of research experience has been focused on pathogenesis, therapy, and diagnosis for Alzheimer’s disease (AD) and fungal disease.• Highly productive and self-motivated, with proven track record of 13 peer-reviewed publications and completed New Investigator Research Grant (2015).• 10 years of Drug discovery such as generation, development, and purification of Monoclonal antibody/Recombinant anti-idiotypic scFv antibody by antibody engineering as therapeutic protein for leading to a clinical use.• Having 5 years of broad experience in pharmaceutical industry, specifically in Formulation and Research Development of sustained and conventional release solid orals dosage forms, process optimization, scale-up, exhibit batches and further coordinated for dossier submission for USFDA.My primary expertise is in Monoclonal Antibody generation and development, Antibody Engineering, Phage display and Panning, Octet and Biacore analysis, Protein purification, Confocal Microscopy, Molecular biology techniques like PCR, ELISA, Molecular cloning and Hybridoma and Neuroblastoma cell culture works.
Listed skills include Western Blotting, Monoclonal Antibodies, Immunohistochemistry, Molecular Biology, and 7 others.
Current workplace
Senthil Kumar Krishnaswamy's current company
Company context helps verify the profile and gives searchers a useful next step.
Astellas Pharma Us
9 roles
Senthil Kumar Krishnaswamy work experience
A career timeline built from the work history available for this profile.
Scientist I
Aug 2018 - Oct 2021
Scientist
National Institute Of Health
Feb 2018 - Aug 2018
Postdoctoral Fellow
Nyu Langone Medical Center
- Project Aim: Immunotherapeutic and diagnostics applications for AD using mouse model and Drosophila Melanogaster.
- Translational Research: Antibody/scFv based diagnostics and treatment for tauopathy in AD and other neurodegenerative diseases.
- Established In vivo imaging system (IVIS) to detect tauopathy in various transgenic mouse models using scFv/antibody.
- scFv antibody treatment for tauopathy using Drosophila melanogaster as a model organism.
- Characterization of Monoclonal antibody/scFv-peptides interaction using Surface Plasmon Resonance (BIAcore) analysis.
Jan 2011 - Jan 2018
Phd
- Project Aim: HM-1 Yeast killer toxin and its exploitation as a therapeutic potential scFv anti-idiotypic antibody.
- scFv phage library preparation from HM-1 neutralizing monoclonal antibody (nmAb-KT).
- Development, engineering and characterization of anti-idiotypic single-chain antibodies (scFv) for fungal pathogens.
- In-vitro phage-display technology, we have uncovered a screening system that allows: (a) antigen-specific target selection using competitive panning elution with the original antigen (HM-1), and (b) pathogen-specific.
- Investigated that killer toxin (HM-1)-like anti-idiotypic scFv’s exhibits strong antifungal activity against medically important pathogenic and non-pathogenic fungi, such as Candida albicans, Aspergillus fumigatus and.
Dec 2006 - Dec 2010
Research Executive
- Formulation and development of sustained release and conventional dosage forms of an abbreviated new drug applications (ANDA) filing for FDA.
- Successfully completed product cycle from drug product development, process optimization, scale-up, exhibit batches and further coordinated for dossier submission of Divalproex sodium delayed release tablets for USFDA.
Oct 2004 - Dec 2006
Research Associate
Spic Pharmaceuticals
- Formulation and development of solid orals dosage forms such as tablets, capsules and liquid orals for domestic market.
- Preparation of Standard operating procedures (SOP) and dosage form manufacturing document preparation.
Aug 2002 - Oct 2004
Production Chemist
The Madras Pharmaceuticals
Manufacturing of solid orals dosage forms such as tablets, capsules and liquid orals for domestic market.
Jun 1999 - May 2000
Training Chemist
Manufacturing of solid orals dosage forms such as tablets, capsules and liquid orals for domestic market.
Jun 1998 - May 1999
5 education records
Senthil Kumar Krishnaswamy education
Doctor Of Philosophy - Phd, Biochemistry And Molecular Biology
Niigata University Of Pharmacy And Applied Life Sciences
Master Of Pharmacy, Pharmaceutics
Periyar College Of Pharmaceutical Sciences
Bachelor Of Pharmacy (B.Pharm.), Pharmacy Subjects
K.M. College Of Pharmacy
Hsc, Higher Secondary
Rock Fort Matriculation Higher Secondary School, Trichy, Tamilnadu, India.
Class X11, Higher Secondary
Rockfort Matriculation Higher Secondary School
FAQ
Frequently asked questions about Senthil Kumar Krishnaswamy
Quick answers generated from the profile data available on this page.
What company does Senthil Kumar Krishnaswamy work for?
Senthil Kumar Krishnaswamy works for Astellas Pharma US.
What is Senthil Kumar Krishnaswamy's role at Astellas Pharma US?
Senthil Kumar Krishnaswamy is listed as Scientist II at Astellas Pharma US.
What is Senthil Kumar Krishnaswamy's email address?
AeroLeads has found 1 work email signal at @astellas.com for Senthil Kumar Krishnaswamy at Astellas Pharma US.
What is Senthil Kumar Krishnaswamy's phone number?
AeroLeads has found 3 phone signal(s) with area code 212, 631 for Senthil Kumar Krishnaswamy at Astellas Pharma US.
Where is Senthil Kumar Krishnaswamy based?
Senthil Kumar Krishnaswamy is based in United States, United States, United States while working with Astellas Pharma US.
What companies has Senthil Kumar Krishnaswamy worked for?
Senthil Kumar Krishnaswamy has worked for Astellas Pharma Us, Abbott, National Institute Of Health, Nyu Langone Medical Center, and Niigata University Of Pharmacy And Applied Life Sciences.
How can I contact Senthil Kumar Krishnaswamy?
You can use AeroLeads to view verified contact signals for Senthil Kumar Krishnaswamy at Astellas Pharma US, including work email, phone, and LinkedIn data when available.
What schools did Senthil Kumar Krishnaswamy attend?
Senthil Kumar Krishnaswamy holds Doctor Of Philosophy - Phd, Biochemistry And Molecular Biology from Niigata University Of Pharmacy And Applied Life Sciences.
What skills is Senthil Kumar Krishnaswamy known for?
Senthil Kumar Krishnaswamy is listed with skills including Western Blotting, Monoclonal Antibodies, Immunohistochemistry, Molecular Biology, Confocal Microscopy, Translational Research, Protein Purification, and Antibody Engineering.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial